Harmony Biosciences (HRMY)
(Delayed Data from NSDQ)
$27.28 USD
+0.52 (1.94%)
Updated Oct 3, 2025 04:00 PM ET
After-Market: $27.18 -0.10 (-0.37%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth A Momentum A VGM
Fundamental Charts
About Market Cap
As of the previous market close, Harmony Biosciences Holdings, Inc. has a market cap of $1.54B, which represents its share price of $26.76 multiplied by its outstanding shares number of 57.53M. As a small-cap company, HRMY's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
HRMY 27.28 +0.52(1.94%)
Will HRMY be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for HRMY based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for HRMY
HRMY Stock Down as Fragile X Syndrome Study Fails to Meet Goal
Can Cannabis Stocks Reverse Their Prolonged Downtrend?
HRMY: What are Zacks experts saying now?
Zacks Private Portfolio Services
Harmony Biosciences Holdings, Inc. (HRMY) Misses Q2 Earnings and Revenue Estimates
Analysts Estimate Stoke Therapeutics, Inc. (STOK) to Report a Decline in Earnings: What to Look Out for
Harmony Biosciences Holdings, Inc. (HRMY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Other News for HRMY
Death Cross appears for HRMY after 1.94% move
Is HRMY ready to make a move? NR7 shows up after dropping 0.59%
New 52 Week Low appears for HRMY after 2.32% move
NR7 appears for HRMY after 0.29% move
Lower Bollinger Band Walk appears for HRMY after 0.47% move